Multidrug-resistant and extensively drug-resistant tuberculosis in the Omsk region: trends and characteristics
https://doi.org/10.17238/PmJ1609-1175.2018.4.95-100
Abstract
About the Authors
O. A. PasechnikRussian Federation
A. A. Zimoglyad
Russian Federation
I. V. Yarusova
Russian Federation
S. V. Vitriv
Russian Federation
A. I. Blokh
Russian Federation
References
1. Нечаева О.Б. Эпидемическая ситуация по ВИЧ-инфекции в России. URL: http://mednet.ru/images/stories/files/ CMT/2016vich.pdf (дата обращения: 18.04. 2018 г.)
2. Стерликов С.А., Галкин В.Б., Попова Н.М. [и др.]. Определение ожидаемой распространенности туберкулеза с множественной и широкой лекарственной устойчивостью методом математического моделирования в учреждениях уголовноисполнительной системы Российской Федерации // Медицинский альянс. 2018. № 1. С. 33-41
3. Туберкулез в Российской Федерации 2011 г.: аналитический обзор статистических показателей, используемых в Российской Федерации и в мире. М., 2013. 280 с
4. Федеральные клинические рекомендации по диагностике и лечению туберкулеза органов дыхания с множественной и широкой лекарственной устойчивостью возбудителя. URL: http://roftb.ru/netcat_files/doks2015/3final.pdf (дата обращения: 24.04.2018 г.)
5. Anti-tuberculosis drug resistance in the world: the WHO/ IUATLD global project on anti-tuberculosis drug resistance surveillance 2002-2007. Geneva, Switzerland: World Health Organization, 2008. 120 p.
6. Eker В., Ortmann J., Migliori G.B. [et al]. Multidrug- and Extensively Drug-Resistant Tuberculosis, Germany // Emerging Infectious Diseases. 2008. Vol. 14, No. 11. P. 1700-1706.
7. Faustini A., Hall A.J., Perucci C.A. Risk factors for multidrug resistant tuberculosis in Europe: a systematic review // Thorax. 2006.Vol. 61. P 158-163.
8. Gandhi N.R., Nunn P, Dheda K. [et al.]. Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis // Lancet. 2010. Vol. 375, No. 9728. P 1830-1843.
9. Global tuberculosis report; Document 2017 (WHO/HTM/ TB/2004.343) [Internet] Geneva: World Health Organization, 2017. [cited 2018 May 4]. URL: http://apps.who.int/iris/bitstream/handle/10665/259366/9789241565516-eng.pdf (date of access: 24.04.2018).
10. He X.-C., Tao N.-N., Liu Y. [et al.]. Epidemiological trends and outcomes of extensively drug-resistant tuberculosis in Shandong, China // BMC Infect. Dis. 2017. Vol. 17, No. 1. P. 555.
11. Marks S.M., Flood J., Seaworth В. [et al.]. Treatment practices, outcomes, and costs of multidrug-resistant and extensively drug-resistant tuberculosis, United States, 2005-2007 // Emerging Infectious Diseases. 2014. Vol.20, No. 5. P 812-821.
12. Qi Y.-C., Ma M.-J., Li D.-J. [et al.]. Multidrug-resistant and extensively drug-resistant tuberculosis in multi-ethnic region, Xinjiang Uygur Autonomous region, China // PLoS ONE. 2012. Vol. 7, No. 2. P. e32103.
13. Raviglione M. XDR-TB: entering the post-antibiotic era? // Int. J. Tuberc. Lung Dis. 2006. Vol. 10. P 1185-1187.
14. Systematic screening for active tuberculosis: principles and recommendations: Document no 2013 (WHO/HTM/ TB/2013b04) [Internet] Geneva: World Health Organization; 2013. [cited 2018 May]. URL: http://www.who.int/tb/publications/Final_TB_Screening_guidelines.pdf (date of access: 24.04.2018).
15. Wright A., Zignol M., Van Deun A. [et al.]. Epidemiology of antituberculosis drug resistance 2002-07: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance // Lancet. 2009. Vol. 373. P. 1861-1873.
Review
For citations:
Pasechnik O.A., Zimoglyad A.A., Yarusova I.V., Vitriv S.V., Blokh A.I. Multidrug-resistant and extensively drug-resistant tuberculosis in the Omsk region: trends and characteristics. Pacific Medical Journal. 2018;(4):95-100. (In Russ.) https://doi.org/10.17238/PmJ1609-1175.2018.4.95-100